Brain Cancer Market - A Global and Regional Analysis

2.1North America
     2.1.1Key Findings
     2.1.2Market Dynamics
     2.1.3Market Sizing and Forecast
          2.1.3.1North America Brain Cancer Market (by Country)
                 2.1.3.1.1U.S.
                 2.1.3.1.2Canada
  2.2Europe
     2.2.1Key Findings
     2.2.2Market Dynamics
     2.2.3Market Sizing and Forecast
          2.2.3.1Europe Brain Cancer Market (by Country)
                 2.2.3.1.1Germany
                 2.2.3.1.2France
                 2.2.3.1.3Italy
                 2.2.3.1.4U.K.
                 2.2.3.1.5Rest-of-Europe
  2.3Asia-Pacific
     2.3.1Key Findings
     2.3.2Market Dynamics
     2.3.3Market Sizing and Forecast
          2.3.3.1Asia-Pacific Brain Cancer Market (by Country)
                 2.3.3.1.1China
                 2.3.3.1.2Japan
                 2.3.3.1.3India
                 2.3.3.1.4Rest-of-Asia-Pacific
  2.4Rest-of-the-World
     2.4.1Key Findings
     2.4.2Market Dynamics
     2.4.3Market Sizing and Forecast

3.1Competitive Landscape
     3.1.1Key Strategies and Developments by Company
          3.1.1.1Funding Activities
          3.1.1.2Mergers and Acquisitions
          3.1.1.3Regulatory Approvals
          3.1.1.4Partnerships, Collaborations and Business Expansions
     3.1.2Key Developments Analysis
  3.2Company Profiles
     3.2.1Merck & Co., Inc.
          3.2.1.1Company Overview
          3.2.1.2Product Portfolio
          3.2.1.3Target Customers/End Users
          3.2.1.4Key Personnels
          3.2.1.5Analyst View
     3.2.2Novartis AG
          3.2.2.1Company Overview
          3.2.2.2Product Portfolio
          3.2.2.3Target Customers / End Users
          3.2.2.4Key Personnels
          3.2.2.5Analyst View
     3.2.3Genentech
          3.2.3.1Company Overview
          3.2.3.2Product Portfolio
          3.2.3.3Target Customers / End Users
          3.2.3.4Key Personnels
          3.2.3.5Analyst View
     3.2.4Orbus Therapeutics
          3.2.4.1Company Overview
          3.2.4.2Product Portfolio
          3.2.4.3Target Customers / End Users
          3.2.4.4Key Personnels
          3.2.4.5Analyst View
     3.2.5VBL Therapeutics
          3.2.5.1Company Overview
          3.2.5.2Product Portfolio
          3.2.5.3Target Customers / End Users
          3.2.5.4Key Personnels
          3.2.5.5Analyst View
     3.2.6DNAtrix
          3.2.6.1Company Overview
          3.2.6.2Product Portfolio
          3.2.6.3Target Customers / End Users
          3.2.6.4Key Personnels
          3.2.6.5Analyst View

Research Methodology

Table:Global Brain Cancer Market, Dynamics and Impact Analysis
Table:Global Brain Cancer Market, Regulatory Landscape
Table:Global Brain Cancer Market, (by Region), $Million, 2023-2035

Figure:Global Brain Cancer Market, Dynamics Impact Analysis
Figure:Global Brain Cancer Market, Coverage
Figure:Global Brain Cancer Market, Key Trends, Impact Analysis
Figure:Global Brain Cancer Market, Competitive Landscape, January 2022- April 2025